Rock Springs Capital Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,685,000
| Closed | -$22.2M | – | 141 |
|
|
2019
Q4 | $22.2M | Sell |
3,685,000
-140,000
| -4% | -$844K | 0.7% | 56 |
|
|
2019
Q3 | $13.8M | Buy |
3,825,000
+875,000
| +30% | +$3.15M | 0.55% | 60 |
|
|
2019
Q2 | $7.91M | Buy |
2,950,000
+250,000
| +9% | +$670K | 0.29% | 87 |
|
|
2019
Q1 | $7.99M | Buy |
2,700,000
+375,000
| +16% | +$1.11M | 0.31% | 90 |
|
|
2018
Q4 | $3.7M | Sell |
2,325,000
-75,000
| -3% | -$119K | 0.17% | 109 |
|
|
2018
Q3 | $8.83M | Buy |
2,400,000
+50,000
| +2% | +$184K | 0.32% | 90 |
|
|
2018
Q2 | $6.65M | Buy |
2,350,000
+100,000
| +4% | +$283K | 0.26% | 108 |
|
|
2018
Q1 | $8.35M | Hold |
2,250,000
| – | – | 0.36% | 90 |
|
|
2017
Q4 | $6.48M | Buy |
2,250,000
+118,600
| +6% | +$342K | 0.29% | 95 |
|
|
2017
Q3 | $9.57M | Buy |
2,131,400
+406,400
| +24% | +$1.82M | 0.44% | 74 |
|
|
2017
Q2 | $7.92M | Buy |
1,725,000
+225,000
| +15% | +$1.03M | 0.4% | 74 |
|
|
2017
Q1 | $6.32M | Buy |
1,500,000
+125,000
| +9% | +$526K | 0.36% | 78 |
|
|
2016
Q4 | $5.68M | Buy |
1,375,000
+59,000
| +4% | +$244K | 0.38% | 73 |
|
|
2016
Q3 | $10.7M | Buy |
1,316,000
+3,500
| +0.3% | +$28.4K | 0.67% | 50 |
|
|
2016
Q2 | $10.2M | Buy |
1,312,500
+92,500
| +8% | +$722K | 0.76% | 44 |
|
|
2016
Q1 | $9.42M | Buy |
1,220,000
+115,000
| +10% | +$888K | 0.79% | 41 |
|
|
2015
Q4 | $11.9M | Sell |
1,105,000
-20,000
| -2% | -$216K | 0.9% | 36 |
|
|
2015
Q3 | $7.77M | Buy |
1,125,000
+25,000
| +2% | +$173K | 0.63% | 57 |
|
|
2015
Q2 | $9.75M | Buy |
1,100,000
+500,000
| +83% | +$4.43M | 0.71% | 46 |
|
|
2015
Q1 | $5.92M | Buy |
600,000
+235,000
| +64% | +$2.32M | 0.55% | 64 |
|
|
2014
Q4 | $4.47M | Buy |
+365,000
| New | +$4.47M | 0.52% | 57 |
|